Prevalence of dyslipidaemia in apparently healthy professionals in asaba, South South Nigeria

Nigerian Journal of Clinical Practice

Volumn 11, Issue 4, 2008, Pages 330-335

  Odenigbo, C U ^a   Oguejiofor, O C ^a   Odenigbo, U M ^a   Ibeh, C C ^a   Ajaero, C N ^a   Odike, M A C ^b  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b AMBROSE ALLI UNIVERSITY   (Nigeria)

Author keywords

ATP iii (adult treatment panel iii); Dyslipidaemia; NCEP (national cholesterol education programme); Prevalence

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SOCIOECONOMICS;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; TRIGLYCERIDES;

EID: 65349180226     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Houterman S, Verschuren WMM, Oomen CM, Boersma-Cobbaert CM, Kromhout D. Trends in total and high-density lipoprotein cholesterol and their determinants in the Netherlands between 1993 and 1997. Inter Jour Epidemiol 2001; 30: 1063 1070
2. World Health Organization (WHO). Familial Hypercholesterolaemia (FH): Report of a WHO consultation: WHO/HGN/CONS/98.7
3. Ballantyne CM, Grundy SM, Oberman A et al. Hyperlipidaemia: diagnostic and therapeutic perspectives. J Clin Endocrinol Metab 2000; 85: 2089-2097.
4. Coronary heart disease mortality trends among whites and blacks- Appalachia and United States, 1980-1993 MMWR Morb Mortal Wkly Rep 1998; 47: 1005-1012.
5. Gundy P. Cardiovascular diseases remain nations leading cause of death. JAMA 1992; 267: 335-338.
6. Wilson PW. Established risk factors and coronary artery disease: The Framingham study. Am JHypertens 1994; 7: 75-80.
7. 7. Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837 (Pubitemid 28213628)
8. The Expert Panel. Second Report of the Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults. NIH Publication No. 93-3095. US Government Printing Office, Washington, DC, 1993.
9. 9. Stamler J, Daviglus ML, Garside DB et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to longterm coronary, cardiovascular and all cause mortality and to longevity. JAMA 2000; 284: 311-321. (Pubitemid 30469857)
10. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: Implications for clinical management. Atherosclerosis 1999; 142: 105-115.
11. Verschuren WMM, Blokstra A, Boerma GJM, Kromhout D. Trends in serum total cholesterol level in 110,000 young adults in the Netherlands-1974 to 1986. Am J Epidemiol 1991; 134: 290-302.
12. Law MR, Wald NJ, Thompson SG By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994; 308: 367-372.
13. Gould AL, Rossouw JE, Santanello NC et al. Cholesterol reduction yields clinic benefit: Impact of statin trials. Circulation 1998; 97: 946-954
14. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-3026.
15. Report of the National cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults. The Expert Panel. Arch Intern Med 1988; 148: 36-41.
16. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-799.
17. Witztum JL, Steinberg D. Role of oxidized low-density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1789
18. Craig WY, Palomaki FE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784-788
19. Datilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320-328
20. Ernst N, Fisher M, Smith W. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Program Prevalence study. Circulation 1980; 62 (Suppl iv): 41-52
21. Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 1994; 22: 477-521
22. Mensink RP, Katan MB. Effects of dietary trans fatty acids on high-density and lowdensity lipoprotein cholesterol levels in healthy subjects. N Engl JMed 1990; 323: 439-445.
23. Adedeji OO. Diet, alcohol consumption, smoking and exercise as determinants of blood lipid levels of Nigerians. WAJM 2000; 19(4): 283-285.
24. 24. Gordon T, Castelli WP, Hjartland MC et al. High density lipoprotein as a protective factor against coronary artery disease. The Framingham study. Am J Med 1977; 62: 707 (Pubitemid 8110784)
25. Kinosian B, Glick H, Garland G Cholesterol and coronary heart disease: Predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641.
26. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population based prospective studies. J Cardiovasc Risk 1996; 3: 213-218
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel ATPIII). JAMA 2001; 285: 2486-2491
28. Genest JJ, Martin-Munley SS, McNamara JR et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2025-2031
29. Ahaneku JE, Dioka CE, Ndefo JC. Cholesterol concentrations in diabetic patients in Nnewi, Nigeria. Eur J Clin Chem Clin Biochem 1996; 34: 273-277
30. Agboola-Abu CF, Onabolu A. Plasma lipid levels in patients attending Igbinedion hospital and medical research centre, Okada, Edo State Nigeria. The Nigerian Society of Endocrinology and Metabolism (NSEM) Scientific Conference and Annual General Meeting 1999 (Abstract), p12.
31. Sacks FM, Castelli WP, Donner A. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med 1975; 292: 1148-1151.
32. 32. Thorogood M, Carter R, Benfield L, McPherson K, Mann J. Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J 1987; 295: 351-353. (Pubitemid 17118768)